Catalyst Wire Dossier Catalyst Wire Dossier

Racotumomab

racotumomab · Laboratorio Elea Phoenix S.A.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Racotumomab, covering 2014-07-10 to 2023-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Racotumomab in Patients With High-risk Neuroblastoma [Phase 2]

See pricing